See also this year's filing and all EDGAR filings for this company.
PDF Report 0001070336_2014_Achillion_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001070336, Achillion Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 124,782,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,265,000 |
| 3 | remainder_Assets | 36,370,000 |
| 4 | LiabilitiesCurrent | 9,403,000 |
| 5 | LiabilitiesNoncurrent | 56,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 12,741,000 |
| 9 | ResearchAndDevelopmentExpense | 46,736,000 |
| 10 | remainder_Expenses | 52,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 582,000 |
| 13 | remainder_ComprehensiveNetIncome | -13,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 162,417,000 |
| 1 | Liabilities | 9,459,000 |
| 2 | Expenses | 59,529,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 152,958,000 |
| 5 | NetIncome | -58,947,000 |
| 6 | ComprehensiveNetIncome | -58,953,500 |
| 7 | BaseVar | 116,000,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.19 |
| 9 | EconomicCapitalRatio | 3.82 |
Edgar->Model Mapping
Feature Distribution
Change over Time
